Multiplex immune serum biomarker profiling in sarcoidosis and systemic sclerosis
Paul Beirne(St. Joseph’s Healthcare Hamilton), Peter Kelleher(St. James's Hospital), Pallav L. Shah(Guy's and St Thomas' NHS Foundation Trust), CP Denton(The Royal Free Hospital), Athol U. Wells(St Thomas' Hospital), David Abraham(Christ University), P. Charles(Lung Institute), R M du Bois(National Jewish Health), Ken I. Welsh(Genomics (United Kingdom)), P. Pantelidis(Lung Institute)
Cited by 65
Related Papers
An Official American Thoracic Society/European Respiratory Society Statement: Update of the International Multidisciplinary Classification of the Idiopathic Interstitial Pneumonias
|American Journal of Respiratory and Critical Care Medicine|2013|4.3k
Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline
|American Journal of Respiratory and Critical Care Medicine|2018|4.1k
Nintedanib in Progressive Fibrosing Interstitial Lung Diseases
|New England Journal of Medicine|2019|2.3k
Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach
|Annals of the Rheumatic Diseases|2003|769
Effectiveness and Safety of Bronchial Thermoplasty in the Treatment of Severe Asthma: A Multicenter, Randomized, Double-Blind, Sham-Controlled Clinical Trial
|American Journal of Respiratory and Critical Care Medicine|2009|686